---
title: "U L MEDICINES LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d30d7af1-22b3-5c92-869f-79d59bd4ae49
json: https://whiteintel.dev/api/public/dossier/d30d7af1-22b3-5c92-869f-79d59bd4ae49
identifier: oo:GB-COH-06120521
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# U L MEDICINES LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06120521`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d30d7af1-22b3-5c92-869f-79d59bd4ae49  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d30d7af1-22b3-5c92-869f-79d59bd4ae49  

## Cross-source identity

The same real-world entity, resolved across sources:

- **U L MEDICINES LIMITED** — GLEIF · `lei:54930077U3642JKBIG60` — https://whiteintel.dev/entity/5cbfcfd5-5730-57b6-9ec4-8de08628cfef

## Ownership & control

### Owners / controllers

- **QUANTUM PHARMACEUTICAL LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/c488a0d1-550f-5f25-ac3b-ad733e534518
- **QUANTUM PHARMACEUTICAL LIMITED** (beneficial owner) — https://whiteintel.dev/entity/c488a0d1-550f-5f25-ac3b-ad733e534518
- **CLINIGEN PHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c73b61a9-95e6-57e2-b6e3-10586e881102

### UBO chain (walk to the ultimate owner)

A **39-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06120521`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2007-02-21
- **Registered office:** 25 Bedford Square, Bloomsbury, London, WC1B 3HH, United Kingdom
- **SIC:** 99999

### Officers

- ADAIR, Richard Edward — secretary · appointed 2024-04-30
- BROOKSBANK, Stephanie Jane — director · British · appointed 2026-04-28
- PALING, Richard John — director · British · appointed 2019-03-19
- SETHI, Varun — director · Indian · appointed 2026-01-22
- MILLER, Amanda — secretary · appointed 2017-11-02 · resigned 2023-01-16
- SMITH, Linda Maria — secretary · British · appointed 2007-02-21 · resigned 2012-02-18
- SUCH, Martin John — secretary · British · appointed 2012-02-18 · resigned 2015-12-01
- SWINHOE, Craig Robert — secretary · appointed 2015-12-01 · resigned 2017-11-02
- BROWN, Catherine Jane — director · British · appointed 2016-03-16 · resigned 2017-09-05
- BRYANT, David John — director · British · appointed 2019-02-01 · resigned 2024-01-26
- CHARTON, Jerome Marie Joseph — director · Swiss · appointed 2024-04-30 · resigned 2025-10-08
- FISHER, Brian James — director · British · appointed 2015-03-03 · resigned 2017-12-22
- MATTHEWS, Andrew Paul — director · British · appointed 2016-05-11 · resigned 2017-03-01
- MURRAY, Gerard Thomas — director · British · appointed 2017-01-23 · resigned 2017-11-02
- PETRIE, Graeme — director · British · appointed 2018-04-13 · resigned 2019-02-01
- RIGG, Christian Alexander — director · British · appointed 2016-03-08 · resigned 2017-01-27
- SANSON, David Alan — director · British · appointed 2016-03-16 · resigned 2021-06-30
- SCAIFE, Andrew John — director · British · appointed 2012-02-18 · resigned 2015-12-01
- SMITH, Linda Maria — director · British · appointed 2008-02-22 · resigned 2012-02-18
- SMITH, Paul — director · British · appointed 2007-02-21 · resigned 2012-02-18

### Beneficial owners (Persons with Significant Control)

- [Clinigen Pharma Limited](https://whiteintel.dev/entity/c73b61a9-95e6-57e2-b6e3-10586e881102) — 75–100% shares · corporate PSC · England — since 2021-06-25
- [Quantum Pharmaceutical Limited](https://whiteintel.dev/entity/c488a0d1-550f-5f25-ac3b-ad733e534518) — 75–100% votes · corporate PSC · United Kingdom — ceased 2021-06-25

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06120521
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06120521

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **U L MEDICINES LIMITED** — https://whiteintel.dev/entity/d30d7af1-22b3-5c92-869f-79d59bd4ae49 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **U L MEDICINES LIMITED**. Human view: https://whiteintel.dev/entity/d30d7af1-22b3-5c92-869f-79d59bd4ae49 · Structured JSON: https://whiteintel.dev/api/public/dossier/d30d7af1-22b3-5c92-869f-79d59bd4ae49._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._